Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19515 | 437 | 34.5 | 75% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BREAST CARCINOMA CELL LINE | Author keyword | 1 | 40% | 0% | 2 |
2 | BIOTINYLATED EPIDERMAL GROWTH FACTOR | Author keyword | 1 | 50% | 0% | 1 |
3 | BREAST CANCER BIOPSIES | Author keyword | 1 | 50% | 0% | 1 |
4 | ENDOMETRIAL ADENOMATOSIS | Author keyword | 1 | 50% | 0% | 1 |
5 | EPIDERMAL GROWTH FACTOR EGF RECEPTOR EGFR | Author keyword | 1 | 50% | 0% | 1 |
6 | GENE DOSAGE PCR | Author keyword | 1 | 50% | 0% | 1 |
7 | IMMUNOCYTOCHEMICAL ASSAYS | Author keyword | 1 | 50% | 0% | 1 |
8 | INTERACTING PATHWAYS | Author keyword | 1 | 50% | 0% | 1 |
9 | INTRON DIFFERENTIAL RNA PCR | Author keyword | 1 | 50% | 0% | 1 |
10 | KASHAN ANAT | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN MAMMARY CARCINOMAS | 5 | 54% | 2% | 7 |
2 | EGF R | 5 | 23% | 4% | 18 |
3 | ACID ETHANOL EXTRACTION | 1 | 50% | 0% | 1 |
4 | FACTOR EGF R | 1 | 50% | 0% | 1 |
5 | FACTOR I IGF 1 R | 1 | 50% | 0% | 1 |
6 | LINE HMT 3522 | 1 | 50% | 0% | 1 |
7 | SOMATOSTATIN SS R | 1 | 50% | 0% | 1 |
8 | FACTOR RECEPTOR STATUS | 1 | 22% | 0% | 2 |
9 | EGF LIKE FACTORS | 0 | 14% | 1% | 3 |
10 | TUMOR BIOPSIES | 0 | 13% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
THE CLINICAL-SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR (EGF-R) IN HUMAN BREAST-CANCER - A REVIEW ON 5232 PATIENTS | 1992 | 479 | 80 | 63% |
Clinical value of epidermal growth factor receptor expression in primary breast cancer | 2005 | 24 | 14 | 50% |
GROWTH-FACTOR SYNTHESIS AND HUMAN BREAST-CANCER PROGRESSION | 1995 | 115 | 101 | 15% |
The relationship between prognostic and predictive factors in the management of breast cancer | 1998 | 97 | 224 | 12% |
Epidermal growth factor receptors in breast cancer: from experiment to clinical practice | 1998 | 0 | 64 | 58% |
EGF RECEPTOR EXPRESSION, REGULATION, AND FUNCTION IN BREAST-CANCER | 1994 | 91 | 109 | 17% |
CELL BIOLOGICAL FACTORS ASSOCIATED WITH THE RESPONSE OF BREAST-CANCER TO SYSTEMIC TREATMENT | 1993 | 46 | 75 | 15% |
Protein tyrosine kinases and cancer | 1997 | 95 | 377 | 8% |
EPIDERMAL GROWTH-FACTOR IN BREAST-CANCER | 1990 | 11 | 85 | 40% |
THE MONOCLONAL-ANTIBODY PROGRAM OF THE CUBAN-INSTITUTE-OF-ONCOLOGY-AND-RADIOBIOLOGY | 1990 | 0 | 11 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KASHAN ANAT | 1 | 50% | 0.2% | 1 |
2 | NN BLOKIN ONCOL | 1 | 50% | 0.2% | 1 |
3 | PATHOL ANAT HUMAN TUMORS | 1 | 50% | 0.2% | 1 |
4 | SEMIOT SURG | 1 | 50% | 0.2% | 1 |
5 | UNITAT REC TRANSLAC TUMORS SOLIDS | 1 | 50% | 0.2% | 1 |
6 | BREAST GYNECOL | 0 | 25% | 0.2% | 1 |
7 | ICRF MOL ONCOL | 0 | 25% | 0.2% | 1 |
8 | OBSTET GYNECOL LARGO GEMELLI 8 | 0 | 20% | 0.2% | 1 |
9 | UNIT BIOINFORMAT BIOSTAT SIGNALLING | 0 | 20% | 0.2% | 1 |
10 | GLENFIELD HOSP NHS TRUST | 0 | 17% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000261558 | TRANSFORMING GROWTH FACTOR ALPHA//TGF ALPHA//HTGF ALPHA |
2 | 0.0000198456 | MED OBSTET GYNECOL1150 FUKUSHIMA//MED RALPH L SMITH PHYSIOL//ADV TECHNOL PLICAT ILTEK |
3 | 0.0000191564 | IMMUNOGENE//MED MOLEC BIOL SHINJUKU KU//ERBB PROTEINS |
4 | 0.0000182526 | C ERBB 2//HER 2 NEU//P185 |
5 | 0.0000179701 | EGF POLYMORPHISM//GEFITINIB THERAPY//INTRON 1 POLYMORPHISM |
6 | 0.0000138480 | NIMOTUZUMAB//H R3//CETUXIMAB |
7 | 0.0000115641 | AEBS//ANTIESTROGEN BINDING SITES//ANALOG II |
8 | 0.0000103517 | ER ICA//IMMUNOCYTOCHEMICAL ASSAY//PROGESTERONE RECEPTORS |
9 | 0.0000096355 | BENIGN MASTOPATHIES//PRIMARY HUMAN BREAST CANCER//BOVINE MAMMARY CELLS |
10 | 0.0000091509 | ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT |